Non-drug Approaches

In a large review study published this week in The Lancet, researchers assessed the effectiveness and potential harms of fourteen different antidepressants for their use in children and adolescents. The negative results, familiar to MIA readers, are now making major headlines.

This Sunday, June 12 at 7pm (EDT) on NBCs Dateline will cover MIA author Steve Francesco's book, Overmedicated and Undertreated: How I Lost My...

The Atlantic covers an experiment by two researchers who tried to use neuroscience techniques to understand the working of an old microprocessor. “Forget attention,...

In the first study of its kind, researchers from Finland found the “most definitive evidence to date” that smoking during pregnancy is associated with the eventual diagnosis of schizophrenia in offspring. After controlling for other potential variables, the study, published ahead of print in The American Journal of Psychiatry, revealed a 38% increased odds of developing symptoms diagnosed as schizophrenia in young adults who were exposed to high levels of nicotine in utero.

In Europe, millions of people live in segregated institutional settings, excluded from mainstream society. Without adequate, person-centered support in the community, institutionalisation will sadly continue.

Are psychotherapists less likely to accept patients that are working class or black? According to a new study from the American Sociological Association, the answer is yes. The study, published in this month’s issue of the Journal of Health and Social Behavior, found that therapists in New York City were less likely to offer appointments to patients who were black or lower working-class.

Imagine if we, as a society, started recognizing trauma, pain, grief, fear, the need for connection and understanding, and oppression without defensiveness or denial. What if, hypothetically, we saw the signs in people who were "defiant," "withdrawn," "oppositional," "depressed," "manic," or otherwise as desperate pleas to have their needs met, and stopped telling them they were sick for doing so? What would a society that actually encouraged expression of emotion, compassion, and empathy look like?

While there has been a recent push to account for financial conflicts of interest in medical research, less attention has been paid to organizations...

Chelsea Roff is the Founder and Director of Eat Breathe Thrive (EBT), a non-profit with an inspired mission to bring yoga, mindfulness, and community support to people struggling with negative body image and disordered eating. I reached out to Chelsea to learn more about her life and organization, which she writes, “…is like AA for people with food and body image issues, plus yoga and meditation.” Chelsea shared her journey from life as a patient to yogi, author, and innovative community organizer. With her permission, you can find this interview below.

In 2011 the American Academy of Pediatrics (AAP) issued guidelines recommending therapy over stimulant drugs as the primary treatment for children diagnosed with ‘ADHD.’ New research from the CDC reveals, however, that children between ages 2 and 5 are still being prescribed medications before receiving the recommended therapy or psychological services. Overall, the researchers found that 75% of these children are being prescribed “ADHD’ drugs while no more than 55% receive psychological treatments. Incredibly, among children on private insurances, the percentage of children receiving psychological services for ‘ADHD’ showed no increase following the 2011 recommendations.

It was somewhat surprising 15+ years ago when Bonnie first began to be challenged (by psychiatrists in particular, who are always being asked about adverse side effects) to answer this question: what are the side effects of taking a broad-spectrum formula? In all these ensuing years, the answer has not changed from her first observations: people repeatedly tell us that in addition to improved mental health and cognitive clarity, they sleep better and they experience relief of constipation. Now, finally, we have evidence for the first of those two ‘side effects’ in the form of an excellent study

In a review editorial for the journal Psychotherapy and Psychosomatics, neurobiology researcher Steven Dubovsky from the University at Buffalo argues against the adoption of...

The Milwaukee Journal Sentinel has issued a watchdog report titled “Illness Inflation” that examines how new medical conditions are often the product of industry...

In Part Two, I discuss strategy and tactics for the Rehumanizing Resistance, including: (1) Traditional, Personal, and Underground Politics; (2) Direct Action and Confrontation: When It Can and Cannot Succeed (3) Organizing: Taking Advantage of the Current Cultural Climate; (4) Alliances and Coalitions; and (5) Film and Media. In Part One, I discussed how the Resistance has been winning scientific battles but losing the war against the expansion of influence of First-Order Psychiatry (which includes American Psychiatric Association and Big Pharma), and how this is due in large part to the First-Order’s effective political tactics and the Resistance’s political naivety.

Psychiatric medications such as antipsychotics and antidepressants account for a huge number of published research studies. This existing research, however, is almost exclusively constrained within a medical model approach, purporting to evaluate medications as treatment for biological brain disorders, and designing studies accordingly. The disease, and how medications presumably affect it, is at the center — with pharmaceutical company financial interests not far behind. That paradigm is starting to change.

A study published in the journal Pediatrics reveals large differences from one pediatrician to the next when it comes to diagnosing and prescribing drugs for ‘ADHD.’ The researchers found that the percentage of children being diagnosed with ‘ADHD’ varied from as high as 16% of patients at some offices to as little as 1% of patients at others. The data also revealed significant but lower variability in the pediatric diagnosis of anxiety and depression.

Mental health campaigner Chrys Muirhead’s blog features video from the All-Party Parliamentary Group for Prescribed Drug Dependence event on 11 May 2016 at Westminster....

For Aeon, Samira Thomas writes that while resilience is attracting a lot of attention from psychology, patience in an underexplored and undervalued virtue in...

“In Nunatsiavut, climate change is already a terrible reality, and it’s taking a heavy toll on mental health,” Ellie Robins reports for the influence....

Researchers at Duke University who studied 183 adolescents for three years found that increased depression associated with poverty may be mediated by epigenetic changes in DNA. The...

While an estimated 74-percent of patients diagnosed with major depression receive a prescription for an antidepressant, new research reveals that mindfulness-based cognitive therapy (MBCT)...

PsychAlive is releasing a new blog and e-course on “Making Sense of Your Life,” with psychologists Lisa Firestone and Dan Siegel. They draw upon the...

Black patients are almost twice as likely as their white counterparts to be diagnosed with schizophrenia while whites are significantly more likely to receive a diagnosis of anxiety or depression, according to a recent study published in the journal Psychiatric Services. The researchers also found that the likelihood of receiving psychotherapy for any diagnosis (34%), regardless of race or ethnicity, was much lower than the likelihood of receiving a psychotropic medication (73%).

In a new article for Scientific American, Diana Kwon reports on how the true risks for suicide and aggression in children and teens taking...

Psychotherapist Chantal Marie Gagnon voices her frustration with social media posts and stigma reduction ads that perpetuate the belief that all mental health issues...